Completed PHASE4 INTERVENTIONAL 3-arm NCT02239445

Intranasal Dexmedetomidine VS Oral Chloral Hydrate for Rescue Sedation During Magnetic Resonance Imaging

Sponsor: Guangzhou Women and Children's Medical Center

Conditions Administration Related Reaction Chloral Hydrate Adverse Reaction Failed Moderate Sedation During Procedure

Interventions chloral hydrate Group high dose dexmedetomidine group low dose dexmedetomidine group

Updated 5 times since 2017 Last updated: May 9, 2015 Started: Sep 30, 2014 Primary completion: May 31, 2015 Completion: May 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02239445, this PHASE4 trial focuses on Administration Related Reaction and Chloral Hydrate Adverse Reaction and remains completed. Sponsored by Guangzhou Women and Children's Medical Center, it has been updated 5 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Guangzhou Women and Children's Medical Center

Data source: Guangzhou Women and Children's Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China